Limited Comparative Evidence Between Metabolic Bariatric Surgery and Incretin‐Based Pharmacotherapy for Weight Loss in Type 2 Diabetes: A Systematic Review and Meta‐Analysis
Oqab Baniowdeh, Ahmad Arar, Yusuf Muslih, Tala Obeidat, Eliana Marji, Shahed Elghandour, Jalal Jbara, Lela Shengelia · 2026
Read Limited Comparative Evidence Between Metabolic Bariatric Surgery and Incretin‐Based Pharmacotherapy for Weight Loss in Type 2 Diabetes: A Systematic Review and Meta‐Analysis by Oqab Baniowdeh, Ahmad Arar, Yusuf Muslih, Tala Obeidat, Eliana Marji, Shahed Elghandour, Jalal Jbara, Lela Shengelia (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13434443.txt.
Description
Baniowdeh and colleagues, writing as a letter in 2026, pool the head to head evidence comparing metabolic bariatric surgery with incretin based drugs for weight loss in type 2 diabetes. Incretin drugs, such as GLP-1 medicines, have reshaped obesity care, while surgery remains the strongest known option. Their systematic review searched three databases for studies from 2021 to 2026 that tested the two approaches head to head in the same patients.
Only four studies qualified, and just two, covering twelve to twenty four months, could be pooled. The pooled result favored surgery by a wide margin in percent of body weight lost. But the confidence range stretched from slightly favoring drugs to hugely favoring surgery. The studies also disagreed strongly with each other. Two longer studies found greater and more durable loss after surgery. Firm choice between scalpel and injection, the authors conclude, awaits proper prospective trials.
Catalog record
| CREATOR | Oqab Baniowdeh, Ahmad Arar, Yusuf Muslih, Tala Obeidat, Eliana Marji, Shahed Elghandour, Jalal Jbara, Lela Shengelia |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 4 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |